| Literature DB >> 29928301 |
Kristiina Nygren1, Mukesh Dubey1, Antonio Zapparata2, Mudassir Iqbal1, Georgios D Tzelepis1,3, Mikael Brandström Durling1, Dan Funck Jensen1, Magnus Karlsson1.
Abstract
Clonostachys rosea is a necrotrophic mycoparasitic fungus, used for biological control of plant pathogenic fungi. A better understanding of the underlying mechanisms resulting in successful biocontrol is important for knowledge-based improvements of the application and use of biocontrol in agricultural production systems. Transcriptomic analyses revealed that C. rosea responded with both common and specific gene expression during interactions with the fungal prey species Botrytis cinerea and Fusarium graminearum. Genes predicted to encode proteins involved in membrane transport, biosynthesis of secondary metabolites and carbohydrate-active enzymes were induced during the mycoparasitic attack. Predicted major facilitator superfamily (MFS) transporters constituted 54% of the induced genes, and detailed phylogenetic and evolutionary analyses showed that a majority of these genes belonged to MFS gene families evolving under selection for increased paralog numbers, with predicted functions in drug resistance and transport of carbohydrates and small organic compounds. Sequence analysis of MFS transporters from family 2.A.1.3.65 identified rapidly evolving loop regions forming the entry to the transport tunnel, indicating changes in substrate specificity as a target for selection. Deletion of the MFS transporter gene mfs464 resulted in mutants with increased growth inhibitory activity against F. graminearum, providing evidence for a function in interspecific fungal interactions. In summary, we show that the mycoparasite C. rosea can distinguish between fungal prey species and modulate its transcriptomic responses accordingly. Gene expression data emphasize the importance of secondary metabolites in mycoparasitic interactions.Entities:
Keywords: Clonostachys rosea; biological control; gene deletion; membrane transporter; mycoparasitism; transcriptome analysis
Year: 2018 PMID: 29928301 PMCID: PMC5999205 DOI: 10.1111/eva.12609
Source DB: PubMed Journal: Evol Appl ISSN: 1752-4571 Impact factor: 5.183
Differentially expressed genes in Clonostachys rosea during interactions with Botrytis cinerea or Fusarium graminearum
| Protein ID | Gene name | Putative function | E‐value | Expression level in CR | Expression level in BC | Expression level in FG |
|---|---|---|---|---|---|---|
| BN869_T00005393 | Hydantoinase/oxoprolinase | 0 | 2.7 |
|
| |
| BN869_T00013543 | 2‐deoxy‐d‐gluconate 3‐dehydrogenase | 1e‐160 | 3.6 |
|
| |
| BN869_T00013396 | Uracil permease | 0 | 5.3 |
|
| |
| BN869_T00010526 |
| Maltose permease (MFS) | 0 | 14.4 |
|
|
| BN869_T00005531 |
| Carboxylic acid transporter (MFS) | 0 | 1.0 |
|
|
| BN869_T00007347 |
| Glucose transporter (MFS) | 0 | 29.5 |
|
|
| BN869_T00006915 | PL1 pectate lyase | 5e‐165 | 28.4 |
|
| |
| BN869_T00008662 | Oxalate decarboxylase | 0 | 0.6 |
| 0.8 | |
| BN869_T00008498 | Cytochrome P450 | 0 | 1.4 |
| 3.7 | |
| BN869_T00004216 | Oxalate decarboxylase | 0 | 14.2 |
| 7.9 | |
| BN869_T00009370 | Cyclopentanone monooxygenase | 0 | 50.8 |
| 65.1 | |
| BN869_T00006567 |
| Lovastatin diketide synthase | 0 | 0.7 |
| 0.3 |
| BN869_T00012005 |
| Nonribosomal peptide synthetase | 0 | 1.6 | 3.0* | 0.6 |
| BN869_T00012311 |
| MFS transporter | 0 | 1.8 |
| 2.5 |
| BN869_T00009923 |
| MFS transporter | 2e‐107 | 7.5 |
| 11.7 |
| BN869_T00007301 |
| Sugar/quinate transporter (MFS) | 0 | 16.8 |
| 23.0 |
| BN869_T00006570 |
| ABC transporter | 0 | 0.7 |
| 0.4 |
| BN869_T00008321 | GH28 alpha‐L‐rhamnosidase | 8e‐180 | 1.1 | 2.2 |
| |
| BN869_T00006501 |
| GH18 killer toxin‐like chitinase | 0 | 1.8 | 1.9 |
|
| BN869_T00000852 |
| Isotrichodermin C‐15 hydroxylase | 0 | 2.7 | 0.9 |
|
| BN869_T00011161 | Norsolorinic acid reductase | 0 | 29.4 | 28.8 |
| |
| BN869_T00006455 |
| MFS transporter | 0 | 0.7 | 0.2 |
|
| BN869_T00007234 |
| MFS transporter | 0 | 0.9 | 0.9 |
|
| BN869_T00010393 |
| Quinate transporter (MFS) | 0 | 1.0 | 1.1 |
|
| BN869_T00000606 |
| FAD‐dependent oxidoreductase | 4e‐127 | 1.4 | 1.6 |
|
| BN869_T00009314 |
| Allantoate permease (MFS) | 0 | 3.6 | 6.9 |
|
| BN869_T00002607 |
| MFS transporter | 0 | 3.8 | 3.6 |
|
| BN869_T00005826 | Potassium channel subunit beta | 0 | 3.9 | 3.3 |
| |
| BN869_T00008599 |
| MFS transporter | 1e‐148 | 8.7 | 9.9 |
|
| BN869_T00007004 |
| MFS transporter | 0 | 12.3 | 11.0 |
|
| BN869_T00009913 |
| Cycloheximide resistance protein (MFS) | 0 | 12.9 | 6.5 |
|
| BN869_T00002418 |
| Peptide transporter | 0 | 27.0 | 32.5 |
|
| BN869_T00010026 |
| ABC transporter | 0 | 0.5 | 0.5 |
|
| BN869_T00011684 |
| Mononucleotide permease (MFS) | 0 | 1.1 | 1.5 |
|
| BN869_T00005590 |
| MFS transporter | 0 | 2.2 | 1.7 |
|
| BN869_T00006700 |
| Pantothenate transporter (MFS) | 0 | 69.3 | 73.1 |
|
| BN869_T00012557 |
| Riboflavin transporter (MFS) | 9e‐169 | 29.3 | 17.0 |
|
| BN869_T00008447 |
| MFS transporter | 0 | 1.6 | 1.4 |
|
| BN869_T00013156 |
| Vitamin H transporter (MFS) | 0 | 2.0 | 1.8 |
|
| BN869_T00000646 |
| MFS transporter | 4e‐145 | 15.4 | 12.5 |
|
| BN869_T00011371 |
| Aminotriazole resistance protein (MFS) | 0 | 45.4 | 43.7 |
|
ABC, ATP‐binding cassette; FAD, flavin adenine dinucleotide; GH, glycoside hydrolase; MFS, major facilitator superfamily; PL, polysaccharide lyase.
E‐value originates from BlastP analysis of the NCBI nonredundant database, or from the SMART protein analysis tool.
Expression level was determined as reads per kilobase of transcript per million mapped reads values. Treatments are CR = expression level in treatment C. rosea vs. C. rosea, BC = expression level in treatment C. rosea vs. B. cinerea, FG = expression level in treatment C. rosea vs. F. graminearum. BC and FG values indicated in bold are significantly (FDR adjusted p ≤ .05) different from CR values in normal font. BC or FG values marked with an asterisk are significantly (FDR adjusted p ≤ .05) higher in the comparison between BC and FG treatments.
Figure 1Expression analysis of Clonostachys rosea genes. Gene expression of C. rosea genes was measured with RT‐qPCR during interactions with Botrytis cinerea (BC) or Fusarium graminearum (FG) or during self‐interactions (CR). Relative gene expression was calculated using the method, normalized by actin (act) expression. Error bars represent standard deviation based on three biological replicates. Different letters indicate statistically significant differences (p ≤ .05) based on the Fisher method
Major facilitator superfamily (MFS) gene numbers in groups evolving nonrandomlya in C. rosea
| MFS classification | MFS annotation | CR | FS | FV | FG | TA | TV | TR | NC |
|---|---|---|---|---|---|---|---|---|---|
| MFS 2.A.1.1.7 | Quinate: H+ symporter |
| 5 | 8 | 10 | 3 | 4 | 3 |
|
| MFS 2.A.1.1.11 | α‐glucoside: H+ symporter |
|
| 20 |
| 9 | 12 |
|
|
| MFS 2.A.1.1.57 | Monosaccharide:H+ symporter |
|
| 4 |
| 2 | 2 | 1 | 4 |
| MFS 2.A.1.1.68 | Glucose transporter/sensor |
|
| 5 |
| 0 | 0 | 0 | 2 |
| MFS 2.A.1.1.83 | Cellobiose/cellodextrin transporter |
|
| 24 |
|
| 8 |
|
|
| MFS 2.A.1.1.119 | Galacturonic acid uptake porter |
| 14 | 14 |
| 10 | 6 | 5 |
|
| MFS 2.A.1.2.33 | Unknown function |
|
|
|
| 6 | 6 | 6 |
|
| MFS 2.A.1.2.77 | Drug resistance transporter |
| 13 | 10 | 11 | 12 | 8 |
|
|
| MFS 2.A.1.2.85 | Peroxisomal phenylacetate transporter |
|
| 1 | 0 |
| 1 | 0 | 0 |
| MFS 2.A.1.2.86 | Peroxisomal isopenicillin N importer |
|
| 16 |
| 14 | 13 |
|
|
| MFS 2.A.1.3.33 | Multidrug resistance porter |
| 3 |
| 3 | 1 | 2 | 1 |
|
| MFS 2.A.1.3.47 | Tri12 trichothecene efflux pump |
| 4 |
| 2 | 0 | 0 | 0 | 2 |
| MFS 2.A.1.3.65 | Multidrug resistance transporter |
|
| 21 |
|
| 19 |
|
|
| MFS 2.A.1.3.68 | Acid resistance and pH homoeostasis |
|
| 0 | 0 |
| 1 | 0 | 0 |
| MFS 2.A.1.13.4 | Riboflavin uptake transporter |
|
| 7 | 6 | 11 | 7 | 8 |
|
| MFS 2.A.1.13.19 | Unknown function |
| 12 | 13 |
| 7 | 9 |
|
|
| MFS 2.A.1.14.3 | Tartrate porter |
|
| 10 |
| 3 | 5 |
|
|
| MFS 2.A.1.14.4 | Dipeptide porter |
|
| 16 | 12 | 9 | 11 |
|
|
| MFS 2.A.1.14.8 | Phthalate porter |
| 1 |
| 2 | 0 | 0 | 0 |
|
| MFS 2.A.1.14.11 | Nicotinate permease |
|
| 37 | 34 | 22 | 23 |
|
|
| MFS 2.A.1.14.17 | Pantothenate: H+ symporter |
|
| 8 | 9 | 2 | 3 | 2 |
|
| MFS 2.A.1.14.36 | Thiamine transporter |
| 8 | 9 | 7 | 9 | 9 |
|
|
| MFS 2.A.1.14.37 | Unknown function |
|
| 2 | 1 | 1 | 0 |
| 2 |
| MFS 2.A.1.14.38 | Inorganic sulphur‐compound transporter |
|
|
|
| 4 | 4 |
|
|
| MFS 2.A.1.16.7 | Ferri‐siderophore transporter |
|
| 7 | 7 | 4 | 6 |
|
|
Species abbreviations: CR, C. rosea; FG, F. graminearum; FS, F. solani; FV, F. verticillioides; NC, N. crassa; TA, T. atroviride; TR, T. reesei; TV, T. virens.
Gene numbers in bold indicates a significant (p ≤ .05) expansion, while gene numbers in italic indicates a significant (p ≤ .05) contraction of gene family size.
MFS classification and annotation are based on BlastP analysis (E‐value ≤ 1e‐5) of the TCDB transporter classification database.
Figure 2Phylogenetic relationships of MFS transporter family 2.A.1.3.65 among Hypocreales. Predicted amino acid sequences of MFS transporters were aligned by MUSCLE and used to construct a phylogenetic tree using the neighbour‐joining method in the MEGA6 software package. Bootstrap support (≥60%) values from 500 iterations are associated with nodes. Species name and protein ID are given for each MFS transporter
Figure 3Phylogenetic relationships of MFS transporter family 2.A.1.2.33 among Hypocreales. Predicted amino acid sequences of MFS transporters were aligned by MUSCLE and used to construct a phylogenetic tree using the neighbour‐joining method in the MEGA6 software package. Bootstrap support (≥60%) values from 500 iterations are associated with nodes. Species name and protein ID are given for each MFS transporter
Figure 4Reverse conservation analysis of family 2.A.1.3.65 MFS transporters. (a) Amino acid conservation was estimated using Rate4Site, based on a MUSCLE alignment of hypocrealean MFS transporters, and plotted as W mean scores (based on S scores for individual positions) in arbitrary units. The black, blue and red lines represent the A, B and C clades indicated in Figure 2, respectively. Regions with signs of functional divergence (W ≥ 1 in one group and W < 0.5 in another group) are indicated. Transmembrane helices and loop structures were predicted with HMMTOP and displayed. (b) Amino acid sequences of regions (indicated by horizontal lines) with signs of functional divergence. Positions with high amino acid diversity (S score ≥1) are indicated by asterisks. Amino acid positions forming parts of transmembrane helices are indicated by T, while positions forming parts of intracellular loops are indicated by i
Figure 5Reverse conservation analysis of family 2.A.1.2.33 MFS transporters. (a) Amino acid conservation was estimated using Rate4Site, based on a MUSCLE alignment of hypocrealean MFS transporters, and plotted as W mean scores (based on S scores for individual positions) in arbitrary units. The blue and red lines represent the A and B clades indicated in Figure 3, respectively. Regions with signs of functional divergence (W ≥ 1 in one group and W < 0.5 in another group) are indicated. Transmembrane helices and loop structures were predicted with HMMTOP and displayed. (b) Amino acid sequences of regions (indicated by horizontal lines) with signs of functional divergence. Positions with high amino acid diversity (S score ≥ 1) are indicated by asterisks. Amino acid positions forming parts of intracellular loops are indicated by i
Expressiona of Clonostachys rosea genes
| Treatment | Genes | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| Zearalenone | 3.8 | ND | 0.8 | 2.4 | D | 2.7* | 18.7 | 11152.3* |
| Zearalenone control | 1.3 | ND | 1.0 | 1.0 | ND | 1.1 | 5.5 | 1.0 |
| Iprodione | ND | ND | 1.0 | 2.0* | ND | 7.4* | 4.3 | ND |
| Boscalid | ND | ND | 3.7* | 4.8* | ND | 4.2* | 1.4 | ND |
| Mefenoxam | ND | ND | 0.4* | 10.9* | ND | 89.3* | 4.6 | D |
| Azoxystrobin | ND | ND | 1.0 | 2.2 | ND | 1.9 | ND | ND |
| Fungicide control | ND | ND | 1.1 | 0.8 | ND | 1.4 | 1.1 | ND |
D, transcripts were detected in ≥3 biological replicates; ND, transcripts were not detected in ≥3 biological replicates.
Relative gene expression in relation with the appropriate control treatment. An asterisk indicates a significant (p ≤ .05) difference compared with the appropriate control treatment as determined by t test.
Figure 6Assay of in vitro antagonism of C. rosea WT and ∆mfs464 mutants. Clonostachys rosea WT and three independent Δmfs464 strains were inoculated in liquid VM media together with F. graminearum. Fungal biomass was estimated after 3 days of interaction by quantifying C. rosea and F. graminearum DNA concentrations using qPCR. Error bars represent standard deviation based on five biological replicates. Different letters indicate statistically significant differences (p ≤ .05) based on the Fisher method